News
Biotech Wednesday: Joining forces to outsmart cancer
Immunetune will be attending Biotech Wednesday on November 20 in Utrecht, the Netherlands. Reach out to us through the networking app or contact us directly in case you'd like to learn more about Immunetune's approach to fight cancer. More information on this meeting...
Neoantigen Summit, 20-22 Nov in Boston
CSO Jeroen van Bergen will be presenting key highlights of Immunetune's preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.
Bio-Europe, Nov 11-13 in Hamburg
Gerben C.M. Zondag, CEO of Immunetune, will attend the BIO-Europe meeting in Hamburg, November 11-13, 2019. Feel free to request a meeting if you'd like to hear more about possible partnering of investment opportunities.
Biotech Wednesday: Joining forces to outsmart cancer
Immunetune will be attending Biotech Wednesday on November 20 in Utrecht, the Netherlands. Reach out to us through the networking app or contact us directly in case you'd like to learn more about Immunetune's approach to fight cancer. More information on this meeting...
Neoantigen Summit, 20-22 Nov in Boston
CSO Jeroen van Bergen will be presenting key highlights of Immunetune's preclinical proof-of-concept results at the Neoantigen summit in Boston, USA on November 20-22, 2019.
Bio-Europe, Nov 11-13 in Hamburg
Gerben C.M. Zondag, CEO of Immunetune, will attend the BIO-Europe meeting in Hamburg, November 11-13, 2019. Feel free to request a meeting if you'd like to hear more about possible partnering of investment opportunities.
Health Holland Research Grant Awarded
Funding for a 2-year research collaboration entitled "Improved personalized vaccines against cancer: quality of T cell immunity matters" has been awarded by Health Holland. In this project Immunetune will collaborate with Leiden University Medical Center to...